Current Studies

Atopic Dermatitis

A prospective observational study of patients receiving Dupixent for Atopic Dermatitis. ENROLLMENT OPEN https://clinicaltrials.gov/ct2...

A phase 3 randomized, placebo-controlled, double-blinded study to evaluate Upadacitinib in adolescents and adult subjects with moderate to severe Atopic Dermatitis. ENROLLMENT CLOSED https://clinicaltrials.gov/ct2...

Psoriasis

A multicenter, open-label, randomized study to assess the pharmacokinetics, safety, and efficacy of two doses of Bimekizumab in adolescent study participants with moderate to severe plaque psoriasis.

https://www.clinicaltrials.gov...

A Phase 3B, multicenter, interventional, open-label study of adult subjects with moderate to severe plaque psoriasis who have a suboptimal response to Secukinumab or Ixekizumab and are switched to Risankizumab.

https://clinicaltrials.gov/ct2...

For more information contact Katy Martz at 660-956-7078 or email [email protected] .

background image

Contact Us

If you would like to call us directly our phone number is +1 (660) 627-7546 or you can use the form below.

Office Hours

Monday:

10:00 am-5:00 pm

Tuesday:

8:00 am-5:00 pm

Wednesday:

8:00 am-5:00 pm

Thursday:

8:00 am-5:00 pm

Friday:

8:00 am-1:00 pm

Saturday:

Closed

Sunday:

Closed